| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/19/2002 | CA2438586A1 Retinoid x receptor modulators |
| 09/19/2002 | CA2437960A1 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | CA2437958A1 Polymeric immunoglobulin fusion proteins that target low-affinity fc.gamma.receptors |
| 09/19/2002 | CA2437756A1 Nucleic acid-associated proteins |
| 09/19/2002 | CA2434611A1 Combined method for treating hormono-dependent disorders |
| 09/18/2002 | EP1241281A1 Tin plating |
| 09/18/2002 | EP1241264A1 Monoclonal antibodies to colon cancer antigen |
| 09/18/2002 | EP1241260A1 69318, a human sodium/calcium exchanger (transporter protein) and uses therefor |
| 09/18/2002 | EP1241259A1 Peptide having pronociceptive properties |
| 09/18/2002 | EP1241258A2 Stem cell factor |
| 09/18/2002 | EP1241257A1 Novel tachykinin-like polypeptides and use thereof |
| 09/18/2002 | EP1241256A1 Novel gene and use thereof |
| 09/18/2002 | EP1241254A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 09/18/2002 | EP1241252A2 Human enteropeptidase-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241251A2 Human prostasin-like protein and nucleic acids encoding the same |
| 09/18/2002 | EP1241250A2 Human dehydrogenase-like protein and nucleic acid encoding it |
| 09/18/2002 | EP1241187A2 Fibilin-like polypeptide and nucleic acids encoding the same |
| 09/18/2002 | EP1241186A2 Human growth arrest specific gene 6 (gas-6) and nucleic acids encoding the same |
| 09/18/2002 | EP1241185A2 Human protocadherin-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241184A2 Human synaptogyrin-like protein and nucleic acids encoding the same |
| 09/18/2002 | EP1241183A2 HUman HCAR-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241181A1 Cd29 pig protein, nucleic acid coding for said protein and the applications thereof |
| 09/18/2002 | EP1241180A2 Human A33 antigen-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241179A2 Human cornichon-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241178A1 Process for producing functional silk fibroin and utilization of the same |
| 09/18/2002 | EP1240904A2 Use of a C1-esterase inhibitor for preventing or delaying xenotransplant rejection in mammals |
| 09/18/2002 | EP1240903A2 Combination of calcium (3S) tetrahydro-3-furanyl(1S,2R)-3- [[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy) propylcarbamate with ritonavir |
| 09/18/2002 | EP1240902A1 Carbonyl stress-ameliorating agents |
| 09/18/2002 | EP1240901A1 Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation |
| 09/18/2002 | EP1240900A1 Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy |
| 09/18/2002 | EP1240899A2 Modulation of Th1/Th2 Cytokine expression by Ribavirin and Ribavirin analogs in actived T-Lymphocytes for treating HCV infections |
| 09/18/2002 | EP1240822A1 Diabetes onset model mammal |
| 09/18/2002 | EP1240521A2 Identification of disease markers involving mass-based-separation |
| 09/18/2002 | EP1240358A1 T1 receptor-like ligand ii and uses thereof |
| 09/18/2002 | EP1240350A1 P2y12 receptor |
| 09/18/2002 | EP1240344A1 Replication incompetent herpes viruses for use in gene therapy |
| 09/18/2002 | EP1240343A2 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 09/18/2002 | EP1240337A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 09/18/2002 | EP1240335A2 Proteases |
| 09/18/2002 | EP1240332A2 Streptococcus pyogenes virulence genes and proteins and their use |
| 09/18/2002 | EP1240331A2 i CHLAMYDIA /i ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 09/18/2002 | EP1240330A2 i PSEUDOMONAS AERUGINOSA /i ANTIGENS |
| 09/18/2002 | EP1240329A2 i STREPTOCOCCUS PNEUMONIAE /i ANTIGENS |
| 09/18/2002 | EP1240327A2 Interferon-like molecules and uses thereof |
| 09/18/2002 | EP1240326A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/18/2002 | EP1240325A2 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 09/18/2002 | EP1240324A2 Polypeptides and nucleic acids encoding same |
| 09/18/2002 | EP1240322A2 Therapeutic uses of lna-modified oligonucleotides |
| 09/18/2002 | EP1240321A2 MODULATION OF i PAX /i -2 FOR CONTROLLED APOPTOSIS OR SURVIVAL OF CELLS |
| 09/18/2002 | EP1240315A2 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof |
| 09/18/2002 | EP1240313A2 Homologues of human heparanase and splice variants thereof |
| 09/18/2002 | EP1240202A2 Inhibitors of complement activation, their preparation and use |
| 09/18/2002 | EP1240201A1 Oxidized apolipoproteins and methods of use |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240196A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 09/18/2002 | EP1240195A2 Polynucleotides and polypeptides encoded thereby |
| 09/18/2002 | EP1240194A2 Novel human protein kinases and protein kinase-like enzymes |
| 09/18/2002 | EP1240193A2 Peptide fragments of colostrinin |
| 09/18/2002 | EP1240187A2 Novel human kinase proteins and polynucleotides encoding the same |
| 09/18/2002 | EP1240186A2 Improvements in or relating to immune responses to hiv |
| 09/18/2002 | EP1240184A2 "dispatched" polypeptides |
| 09/18/2002 | EP1240182A2 Daptomycin analogs and their use as antibacterial agents |
| 09/18/2002 | EP1240181A2 Daptomycin analogs as antibacterial agents |
| 09/18/2002 | EP1240152A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 09/18/2002 | EP1239877A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN $g(a) V?$g(b) 3? RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 09/18/2002 | EP1239876A1 Vaccine compositions |
| 09/18/2002 | EP1239874A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/18/2002 | EP1239873A2 Method for localized administration of fibrinolytic metalloproteinases |
| 09/18/2002 | EP1239872A2 Enzyme treatment for infection |
| 09/18/2002 | EP1239871A1 Use of glp-1 agonists for the inhibition of beta cell degeneration |
| 09/18/2002 | EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1239869A2 Tweak receptor |
| 09/18/2002 | EP1239868A2 Use of an immunosuppressant for increasing an antifungal activity of a lipopetide |
| 09/18/2002 | EP1239867A2 Methods for treating and preventing damage to mucosal tissue |
| 09/18/2002 | EP1239866A1 INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| 09/18/2002 | EP1239863A2 Novel glycosidase inhibitors and their pharmacological uses, in particular for treating diabetes |
| 09/18/2002 | EP1239855A2 Method for the prevention and/or treatment of atherosclerosis |
| 09/18/2002 | EP1239848A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 09/18/2002 | EP1239845A2 Hydroxide-releasing agents as skin permeation enhancers |
| 09/18/2002 | EP1239836A1 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 09/18/2002 | EP1239814A2 Use of the residues from wine production |
| 09/18/2002 | EP1212339A4 2'-o-acetamido modified monomers and oligomers |
| 09/18/2002 | EP1093380B1 Component b as angiogenic agent in combination with human growth factors |
| 09/18/2002 | EP0979239A4 Prevention and treatment of hepatocellular cancer |
| 09/18/2002 | EP0954565A4 Adipogenic differentiation of human mesenchymal stem cells |
| 09/18/2002 | EP0932414B1 USES OF COMPOSITIONS WITH alpha-LACTALBUMEN BASE |
| 09/18/2002 | EP0921808B1 Non-aqueous polar aprotic peptide formulations |
| 09/18/2002 | EP0904285B1 Cyclic adhesion inhibitors |
| 09/18/2002 | EP0873132A4 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO |
| 09/18/2002 | EP0861265B1 use of CASEIN FRAGMENTS as GROWTH PROMOTer |
| 09/18/2002 | EP0842267B1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
| 09/18/2002 | EP0831819B1 Method for inhibiting neoplastic disease in mammals |
| 09/18/2002 | EP0828486B1 Use of pyrrolidine derivatives for treating alcoholism |
| 09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
| 09/18/2002 | EP0789763B1 Icam-4 materials and methods |
| 09/18/2002 | EP0759765B1 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 09/18/2002 | EP0693936B1 Cloned leptospira outer membrane protein |
| 09/18/2002 | EP0592582B1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 09/18/2002 | EP0575357B1 Human follicle stimulating hormone receptor |
| 09/18/2002 | EP0537171B1 CD46 isoforms |